Advances in Management of Pediatric Brain Tumors, Volume 167 encapsulates the latest developments in the field for various types of pediatric brain tumors. By examining these survival gaps, the volume offers insights into strategies for improving outcomes and bridging the gap in care on a global scale. Chapters in this new release include Pediatric-type diffuse low grade gliomak, Pediatric-type diffuse high grade glioma/Diffuse Midline glioma, Ependymoma, Choroid plexus tumors, Embryonal tumors/medulloblastoma, Craniopharyngioma and other sellar-region tumors, and much more.Other sections cover Germ cell tumors, Immunotherapy for pediatric brain tumors, Emerging interventional treatments in the management of pediatric brain tumors, and Management of pediatric brain tumors in low-middle income countries. - Provides the most up-to-date diagnostic criteria for pediatric brain tumors, aligned with the latest CNS WHO classification- Explores the latest breakthroughs in targeted therapies, offering new hope and precision in the treatment of pediatric brain tumors- Includes insights on the unique challenges and innovative approaches to diagnosing and managing pediatric brain tumors in LMICs, aiming to bridge the gap in care and improve global outcomes

Advances in Management of Pediatric Brain Tumors, Volume 167 encapsulates the latest developments in the field for various types of pediatric brain tumors. By examining these survival gaps, the volume offers insights into strategies for improving outcomes and bridging the gap in care on a global scale. Chapters in this new release include Pediatric-type diffuse low grade gliomak, Pediatric-type diffuse high grade glioma/Diffuse Midline glioma, Ependymoma, Choroid plexus tumors, Embryonal tumors/medulloblastoma, Craniopharyngioma and other sellar-region tumors, and much more.Other sections cover Germ cell tumors, Immunotherapy for pediatric brain tumors, Emerging interventional treatments in the management of pediatric brain tumors, and Management of pediatric brain tumors in low-middle income countries. - Provides the most up-to-date diagnostic criteria for pediatric brain tumors, aligned with the latest CNS WHO classification- Explores the latest breakthroughs in targeted therapies, offering new hope and precision in the treatment of pediatric brain tumors- Includes insights on the unique challenges and innovative approaches to diagnosing and managing pediatric brain tumors in LMICs, aiming to bridge the gap in care and improve global outcomes

Advances in Management of Pediatric Brain Tumors, Volume 167 encapsulates the latest developments in the field for various types of pediatric brain tumors. By examining these survival gaps, the volume offers insights into strategies for improving outcomes and bridging the gap in care on a global scale. Chapters in this new release include Pediatric-type diffuse low grade gliomak, Pediatric-type diffuse high grade glioma/Diffuse Midline glioma, Ependymoma, Choroid plexus tumors, Embryonal tumors/medulloblastoma, Craniopharyngioma and other sellar-region tumors, and much more.Other sections cover Germ cell tumors, Immunotherapy for pediatric brain tumors, Emerging interventional treatments in the management of pediatric brain tumors, and Management of pediatric brain tumors in low-middle income countries. - Provides the most up-to-date diagnostic criteria for pediatric brain tumors, aligned with the latest CNS WHO classification- Explores the latest breakthroughs in targeted therapies, offering new hope and precision in the treatment of pediatric brain tumors- Includes insights on the unique challenges and innovative approaches to diagnosing and managing pediatric brain tumors in LMICs, aiming to bridge the gap in care and improve global outcomes